Beryl Drugs standalone net profit declines 35.29% in the June 2022 quarter

9 Aug 2022 , 05:02 PM

Net profit of Beryl Drugs declined 35.29% to Rs 0.22 crore in the quarter ended June 2022 as against Rs 0.34 crore during the previous quarter ended June 2021. Sales rose 6.94% to Rs 4.93 crore in the quarter ended June 2022 as against Rs 4.61 crore during the previous quarter ended June 2021.

Particulars	Quarter Ended
?	Jun. 2022	Jun. 2021	% Var.
Sales	4.93	4.61	7
OPM %	12.17	15.40	–
PBDT	0.47	0.60	-22
PBT	0.22	0.30	-27
NP	0.22	0.34	-35

Powered by Capital Market – Live News